Clinical Trials Browser

Not yet recruiting × Neoplasm Metastasis × eribulin × Clear all

NCT06539559 2024-08-06

Efficacy and Resistant Mechanism of Eribulin and Bevacizumab for Advanced HER2 Negative Breast Cancer

Phase 2 Not yet recruiting

Breast Neoplasms, Neoplasm Metastasis